nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—LYN—systemic lupus erythematosus	0.173	0.344	CbGaD
Vandetanib—LTK—systemic lupus erythematosus	0.164	0.326	CbGaD
Vandetanib—BLK—systemic lupus erythematosus	0.0993	0.197	CbGaD
Vandetanib—FMO3—Dapsone—systemic lupus erythematosus	0.0843	0.382	CbGbCtD
Vandetanib—VEGFA—systemic lupus erythematosus	0.0528	0.105	CbGaD
Vandetanib—ABCG2—Leflunomide—systemic lupus erythematosus	0.0215	0.0973	CbGbCtD
Vandetanib—ABCC1—Cyclosporine—systemic lupus erythematosus	0.015	0.0681	CbGbCtD
Vandetanib—ALB—systemic lupus erythematosus	0.0142	0.0282	CbGaD
Vandetanib—ABCG2—Mycophenolate mofetil—systemic lupus erythematosus	0.0133	0.0601	CbGbCtD
Vandetanib—ABCG2—Hydrocortisone—systemic lupus erythematosus	0.0106	0.0482	CbGbCtD
Vandetanib—ABCG2—Cyclosporine—systemic lupus erythematosus	0.0101	0.0456	CbGbCtD
Vandetanib—ALB—Mycophenolate mofetil—systemic lupus erythematosus	0.00914	0.0414	CbGbCtD
Vandetanib—ABCC1—Methotrexate—systemic lupus erythematosus	0.00795	0.036	CbGbCtD
Vandetanib—ALB—Prednisone—systemic lupus erythematosus	0.00731	0.0331	CbGbCtD
Vandetanib—ABCG2—Dexamethasone—systemic lupus erythematosus	0.00662	0.03	CbGbCtD
Vandetanib—STK10—renal vein—systemic lupus erythematosus	0.00552	0.0821	CbGeAlD
Vandetanib—ABCG2—Methotrexate—systemic lupus erythematosus	0.00532	0.0241	CbGbCtD
Vandetanib—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00378	0.0171	CbGbCtD
Vandetanib—ALB—Methotrexate—systemic lupus erythematosus	0.00367	0.0166	CbGbCtD
Vandetanib—CYP3A4—Dapsone—systemic lupus erythematosus	0.0033	0.015	CbGbCtD
Vandetanib—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00287	0.013	CbGbCtD
Vandetanib—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00287	0.013	CbGbCtD
Vandetanib—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00246	0.0111	CbGbCtD
Vandetanib—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00243	0.011	CbGbCtD
Vandetanib—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0023	0.0104	CbGbCtD
Vandetanib—CYP3A4—Prednisone—systemic lupus erythematosus	0.00229	0.0104	CbGbCtD
Vandetanib—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00217	0.00984	CbGbCtD
Vandetanib—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00143	0.00648	CbGbCtD
Vandetanib—FMO3—urine—systemic lupus erythematosus	0.00121	0.0179	CbGeAlD
Vandetanib—KDR—umbilical vein—systemic lupus erythematosus	0.00115	0.0171	CbGeAlD
Vandetanib—Erlotinib—LTK—systemic lupus erythematosus	0.00106	0.261	CrCbGaD
Vandetanib—LYN—blood plasma—systemic lupus erythematosus	0.00095	0.0141	CbGeAlD
Vandetanib—Afatinib—BLK—systemic lupus erythematosus	0.00091	0.224	CrCbGaD
Vandetanib—Bosutinib—CSK—systemic lupus erythematosus	0.000863	0.212	CrCbGaD
Vandetanib—FLT4—endothelium—systemic lupus erythematosus	0.000831	0.0124	CbGeAlD
Vandetanib—RIPK2—endothelium—systemic lupus erythematosus	0.000826	0.0123	CbGeAlD
Vandetanib—FLT3—blood plasma—systemic lupus erythematosus	0.000812	0.0121	CbGeAlD
Vandetanib—Bosutinib—LYN—systemic lupus erythematosus	0.00069	0.169	CrCbGaD
Vandetanib—TEK—endothelium—systemic lupus erythematosus	0.000668	0.00993	CbGeAlD
Vandetanib—FYN—blood plasma—systemic lupus erythematosus	0.000607	0.00903	CbGeAlD
Vandetanib—PTK6—skin of body—systemic lupus erythematosus	0.000594	0.00883	CbGeAlD
Vandetanib—SRC—endothelium—systemic lupus erythematosus	0.000594	0.00882	CbGeAlD
Vandetanib—KDR—endothelium—systemic lupus erythematosus	0.000546	0.00812	CbGeAlD
Vandetanib—STK10—blood plasma—systemic lupus erythematosus	0.000543	0.00807	CbGeAlD
Vandetanib—SRC—blood plasma—systemic lupus erythematosus	0.000527	0.00784	CbGeAlD
Vandetanib—TYRO3—connective tissue—systemic lupus erythematosus	0.000509	0.00756	CbGeAlD
Vandetanib—BLK—lymphoid tissue—systemic lupus erythematosus	0.000507	0.00754	CbGeAlD
Vandetanib—LYN—connective tissue—systemic lupus erythematosus	0.000506	0.00752	CbGeAlD
Vandetanib—KDR—blood plasma—systemic lupus erythematosus	0.000485	0.00721	CbGeAlD
Vandetanib—TYRO3—skin of body—systemic lupus erythematosus	0.000459	0.00683	CbGeAlD
Vandetanib—FLT3—connective tissue—systemic lupus erythematosus	0.000433	0.00643	CbGeAlD
Vandetanib—LTK—lung—systemic lupus erythematosus	0.000414	0.00615	CbGeAlD
Vandetanib—PTK6—lung—systemic lupus erythematosus	0.000397	0.0059	CbGeAlD
Vandetanib—Bosutinib—BLK—systemic lupus erythematosus	0.000396	0.0973	CrCbGaD
Vandetanib—PLK4—lymphoid tissue—systemic lupus erythematosus	0.000396	0.00589	CbGeAlD
Vandetanib—RIPK2—connective tissue—systemic lupus erythematosus	0.000391	0.00581	CbGeAlD
Vandetanib—STK35—skin of body—systemic lupus erythematosus	0.000383	0.00569	CbGeAlD
Vandetanib—RIPK2—nephron tubule—systemic lupus erythematosus	0.000378	0.00563	CbGeAlD
Vandetanib—VEGFA—nephron tubule—systemic lupus erythematosus	0.000377	0.00561	CbGeAlD
Vandetanib—FMO1—nephron tubule—systemic lupus erythematosus	0.000375	0.00558	CbGeAlD
Vandetanib—ERBB3—connective tissue—systemic lupus erythematosus	0.000374	0.00556	CbGeAlD
Vandetanib—TYRO3—lymphoid tissue—systemic lupus erythematosus	0.000372	0.00553	CbGeAlD
Vandetanib—LYN—lymphoid tissue—systemic lupus erythematosus	0.00037	0.0055	CbGeAlD
Vandetanib—EPHA8—nervous system—systemic lupus erythematosus	0.000367	0.00546	CbGeAlD
Vandetanib—ERBB3—nephron tubule—systemic lupus erythematosus	0.000362	0.00539	CbGeAlD
Vandetanib—PLK4—bone marrow—systemic lupus erythematosus	0.000361	0.00536	CbGeAlD
Vandetanib—EPHA8—central nervous system—systemic lupus erythematosus	0.000354	0.00526	CbGeAlD
Vandetanib—RIPK2—skin of body—systemic lupus erythematosus	0.000353	0.00524	CbGeAlD
Vandetanib—RET—connective tissue—systemic lupus erythematosus	0.000347	0.00516	CbGeAlD
Vandetanib—AXL—connective tissue—systemic lupus erythematosus	0.000345	0.00513	CbGeAlD
Vandetanib—ERBB3—skin of body—systemic lupus erythematosus	0.000338	0.00502	CbGeAlD
Vandetanib—FMO1—kidney—systemic lupus erythematosus	0.00033	0.0049	CbGeAlD
Vandetanib—PLK4—lung—systemic lupus erythematosus	0.000327	0.00486	CbGeAlD
Vandetanib—FLT4—cortex of kidney—systemic lupus erythematosus	0.000326	0.00484	CbGeAlD
Vandetanib—FYN—connective tissue—systemic lupus erythematosus	0.000323	0.00481	CbGeAlD
Vandetanib—VEGFA—cortex of kidney—systemic lupus erythematosus	0.000323	0.0048	CbGeAlD
Vandetanib—SLK—nephron tubule—systemic lupus erythematosus	0.000322	0.00479	CbGeAlD
Vandetanib—FMO1—cortex of kidney—systemic lupus erythematosus	0.000321	0.00478	CbGeAlD
Vandetanib—ERBB3—kidney—systemic lupus erythematosus	0.000318	0.00473	CbGeAlD
Vandetanib—FLT3—lymphoid tissue—systemic lupus erythematosus	0.000316	0.0047	CbGeAlD
Vandetanib—TEK—connective tissue—systemic lupus erythematosus	0.000316	0.0047	CbGeAlD
Vandetanib—CYP3A4—urine—systemic lupus erythematosus	0.000315	0.00468	CbGeAlD
Vandetanib—FYN—nephron tubule—systemic lupus erythematosus	0.000313	0.00466	CbGeAlD
Vandetanib—AXL—skin of body—systemic lupus erythematosus	0.000312	0.00464	CbGeAlD
Vandetanib—EPHA6—nervous system—systemic lupus erythematosus	0.000306	0.00455	CbGeAlD
Vandetanib—BMPR1B—lung—systemic lupus erythematosus	0.000301	0.00447	CbGeAlD
Vandetanib—MAP3K19—lung—systemic lupus erythematosus	0.000301	0.00447	CbGeAlD
Vandetanib—RET—kidney—systemic lupus erythematosus	0.000295	0.00439	CbGeAlD
Vandetanib—EPHA6—central nervous system—systemic lupus erythematosus	0.000295	0.00438	CbGeAlD
Vandetanib—FYN—skin of body—systemic lupus erythematosus	0.000292	0.00434	CbGeAlD
Vandetanib—YES1—connective tissue—systemic lupus erythematosus	0.000292	0.00434	CbGeAlD
Vandetanib—STK35—tendon—systemic lupus erythematosus	0.000291	0.00433	CbGeAlD
Vandetanib—MKNK1—cortex of kidney—systemic lupus erythematosus	0.000291	0.00433	CbGeAlD
Vandetanib—FLT3—bone marrow—systemic lupus erythematosus	0.000288	0.00428	CbGeAlD
Vandetanib—FLT4—lymphoid tissue—systemic lupus erythematosus	0.000287	0.00427	CbGeAlD
Vandetanib—AXL—cortex of kidney—systemic lupus erythematosus	0.000286	0.00426	CbGeAlD
Vandetanib—TYRO3—nervous system—systemic lupus erythematosus	0.000284	0.00422	CbGeAlD
Vandetanib—EPHA5—nervous system—systemic lupus erythematosus	0.000284	0.00422	CbGeAlD
Vandetanib—ABL2—tendon—systemic lupus erythematosus	0.000284	0.00422	CbGeAlD
Vandetanib—LYN—nervous system—systemic lupus erythematosus	0.000283	0.0042	CbGeAlD
Vandetanib—YES1—nephron tubule—systemic lupus erythematosus	0.000283	0.0042	CbGeAlD
Vandetanib—SRC—connective tissue—systemic lupus erythematosus	0.000281	0.00417	CbGeAlD
Vandetanib—IRAK4—lymphoid tissue—systemic lupus erythematosus	0.000279	0.00415	CbGeAlD
Vandetanib—BMPR1B—nervous system—systemic lupus erythematosus	0.000278	0.00414	CbGeAlD
Vandetanib—MAP3K19—nervous system—systemic lupus erythematosus	0.000278	0.00414	CbGeAlD
Vandetanib—SLK—cortex of kidney—systemic lupus erythematosus	0.000276	0.0041	CbGeAlD
Vandetanib—FYN—kidney—systemic lupus erythematosus	0.000275	0.00409	CbGeAlD
Vandetanib—EPHA5—central nervous system—systemic lupus erythematosus	0.000274	0.00407	CbGeAlD
Vandetanib—TYRO3—central nervous system—systemic lupus erythematosus	0.000274	0.00407	CbGeAlD
Vandetanib—ERBB3—lymphoid tissue—systemic lupus erythematosus	0.000273	0.00406	CbGeAlD
Vandetanib—EPHB6—skin of body—systemic lupus erythematosus	0.000273	0.00405	CbGeAlD
Vandetanib—LYN—central nervous system—systemic lupus erythematosus	0.000272	0.00405	CbGeAlD
Vandetanib—TEK—kidney—systemic lupus erythematosus	0.000269	0.004	CbGeAlD
Vandetanib—RIPK2—tendon—systemic lupus erythematosus	0.000269	0.00399	CbGeAlD
Vandetanib—FYN—cortex of kidney—systemic lupus erythematosus	0.000268	0.00398	CbGeAlD
Vandetanib—MAP3K19—central nervous system—systemic lupus erythematosus	0.000268	0.00398	CbGeAlD
Vandetanib—BMPR1B—central nervous system—systemic lupus erythematosus	0.000268	0.00398	CbGeAlD
Vandetanib—VEGFA—tendon—systemic lupus erythematosus	0.000268	0.00398	CbGeAlD
Vandetanib—FMO1—tendon—systemic lupus erythematosus	0.000266	0.00396	CbGeAlD
Vandetanib—IRAK4—tendon—systemic lupus erythematosus	0.000262	0.0039	CbGeAlD
Vandetanib—MAP4K5—cortex of kidney—systemic lupus erythematosus	0.000262	0.00389	CbGeAlD
Vandetanib—TEK—cortex of kidney—systemic lupus erythematosus	0.000262	0.00389	CbGeAlD
Vandetanib—FLT4—bone marrow—systemic lupus erythematosus	0.000262	0.00389	CbGeAlD
Vandetanib—FLT3—lung—systemic lupus erythematosus	0.000261	0.00388	CbGeAlD
Vandetanib—RIPK2—bone marrow—systemic lupus erythematosus	0.00026	0.00387	CbGeAlD
Vandetanib—VEGFA—bone marrow—systemic lupus erythematosus	0.000259	0.00386	CbGeAlD
Vandetanib—KDR—connective tissue—systemic lupus erythematosus	0.000258	0.00384	CbGeAlD
Vandetanib—MKNK1—lymphoid tissue—systemic lupus erythematosus	0.000257	0.00382	CbGeAlD
Vandetanib—STK35—lung—systemic lupus erythematosus	0.000256	0.0038	CbGeAlD
Vandetanib—IRAK4—bone marrow—systemic lupus erythematosus	0.000254	0.00378	CbGeAlD
Vandetanib—RET—lymphoid tissue—systemic lupus erythematosus	0.000254	0.00377	CbGeAlD
Vandetanib—FGR—lymphoid tissue—systemic lupus erythematosus	0.000254	0.00377	CbGeAlD
Vandetanib—SRC—skin of body—systemic lupus erythematosus	0.000253	0.00377	CbGeAlD
Vandetanib—AXL—lymphoid tissue—systemic lupus erythematosus	0.000253	0.00375	CbGeAlD
Vandetanib—EPHB6—cortex of kidney—systemic lupus erythematosus	0.00025	0.00372	CbGeAlD
Vandetanib—KDR—nephron tubule—systemic lupus erythematosus	0.00025	0.00372	CbGeAlD
Vandetanib—ABL2—lung—systemic lupus erythematosus	0.000249	0.0037	CbGeAlD
Vandetanib—YES1—kidney—systemic lupus erythematosus	0.000248	0.00369	CbGeAlD
Vandetanib—STK10—kidney—systemic lupus erythematosus	0.000246	0.00366	CbGeAlD
Vandetanib—EGFR—lung—systemic lupus erythematosus	0.000243	0.00361	CbGeAlD
Vandetanib—YES1—cortex of kidney—systemic lupus erythematosus	0.000242	0.0036	CbGeAlD
Vandetanib—SRC—kidney—systemic lupus erythematosus	0.000239	0.00355	CbGeAlD
Vandetanib—RET—tendon—systemic lupus erythematosus	0.000238	0.00354	CbGeAlD
Vandetanib—FGR—tendon—systemic lupus erythematosus	0.000238	0.00354	CbGeAlD
Vandetanib—AXL—tendon—systemic lupus erythematosus	0.000237	0.00353	CbGeAlD
Vandetanib—FLT4—lung—systemic lupus erythematosus	0.000237	0.00352	CbGeAlD
Vandetanib—STK35—nervous system—systemic lupus erythematosus	0.000237	0.00352	CbGeAlD
Vandetanib—FYN—lymphoid tissue—systemic lupus erythematosus	0.000236	0.00351	CbGeAlD
Vandetanib—RIPK2—lung—systemic lupus erythematosus	0.000236	0.0035	CbGeAlD
Vandetanib—VEGFA—lung—systemic lupus erythematosus	0.000235	0.00349	CbGeAlD
Vandetanib—FMO1—lung—systemic lupus erythematosus	0.000234	0.00348	CbGeAlD
Vandetanib—MKNK1—bone marrow—systemic lupus erythematosus	0.000234	0.00348	CbGeAlD
Vandetanib—TEK—lymphoid tissue—systemic lupus erythematosus	0.000231	0.00343	CbGeAlD
Vandetanib—MAP4K5—lymphoid tissue—systemic lupus erythematosus	0.000231	0.00343	CbGeAlD
Vandetanib—FGR—bone marrow—systemic lupus erythematosus	0.000231	0.00343	CbGeAlD
Vandetanib—LCK—bone marrow—systemic lupus erythematosus	0.000231	0.00343	CbGeAlD
Vandetanib—IRAK4—lung—systemic lupus erythematosus	0.00023	0.00342	CbGeAlD
Vandetanib—SLK—tendon—systemic lupus erythematosus	0.000229	0.0034	CbGeAlD
Vandetanib—STK35—central nervous system—systemic lupus erythematosus	0.000228	0.00339	CbGeAlD
Vandetanib—ERBB3—lung—systemic lupus erythematosus	0.000226	0.00335	CbGeAlD
Vandetanib—PDGFRB—connective tissue—systemic lupus erythematosus	0.000223	0.00332	CbGeAlD
Vandetanib—FYN—tendon—systemic lupus erythematosus	0.000222	0.0033	CbGeAlD
Vandetanib—SLK—bone marrow—systemic lupus erythematosus	0.000221	0.00329	CbGeAlD
Vandetanib—KDR—kidney—systemic lupus erythematosus	0.00022	0.00327	CbGeAlD
Vandetanib—TEK—tendon—systemic lupus erythematosus	0.000217	0.00323	CbGeAlD
Vandetanib—MAP4K5—tendon—systemic lupus erythematosus	0.000217	0.00323	CbGeAlD
Vandetanib—FMO1—nervous system—systemic lupus erythematosus	0.000216	0.00322	CbGeAlD
Vandetanib—FYN—bone marrow—systemic lupus erythematosus	0.000215	0.0032	CbGeAlD
Vandetanib—KDR—cortex of kidney—systemic lupus erythematosus	0.000214	0.00318	CbGeAlD
Vandetanib—MAP2K5—cortex of kidney—systemic lupus erythematosus	0.000214	0.00318	CbGeAlD
Vandetanib—YES1—lymphoid tissue—systemic lupus erythematosus	0.000213	0.00317	CbGeAlD
Vandetanib—IRAK4—nervous system—systemic lupus erythematosus	0.000213	0.00317	CbGeAlD
Vandetanib—MKNK1—lung—systemic lupus erythematosus	0.000212	0.00315	CbGeAlD
Vandetanib—STK10—lymphoid tissue—systemic lupus erythematosus	0.000211	0.00314	CbGeAlD
Vandetanib—MAP4K5—bone marrow—systemic lupus erythematosus	0.00021	0.00313	CbGeAlD
Vandetanib—FGR—lung—systemic lupus erythematosus	0.000209	0.00311	CbGeAlD
Vandetanib—LCK—lung—systemic lupus erythematosus	0.000209	0.00311	CbGeAlD
Vandetanib—ERBB3—nervous system—systemic lupus erythematosus	0.000209	0.00311	CbGeAlD
Vandetanib—FMO1—central nervous system—systemic lupus erythematosus	0.000208	0.0031	CbGeAlD
Vandetanib—AXL—lung—systemic lupus erythematosus	0.000208	0.0031	CbGeAlD
Vandetanib—EPHB6—tendon—systemic lupus erythematosus	0.000208	0.00309	CbGeAlD
Vandetanib—SRC—lymphoid tissue—systemic lupus erythematosus	0.000205	0.00305	CbGeAlD
Vandetanib—IRAK4—central nervous system—systemic lupus erythematosus	0.000205	0.00305	CbGeAlD
Vandetanib—FMO3—lung—systemic lupus erythematosus	0.000202	0.003	CbGeAlD
Vandetanib—PDGFRB—skin of body—systemic lupus erythematosus	0.000202	0.003	CbGeAlD
Vandetanib—ERBB3—central nervous system—systemic lupus erythematosus	0.000201	0.00299	CbGeAlD
Vandetanib—SLK—lung—systemic lupus erythematosus	0.000201	0.00298	CbGeAlD
Vandetanib—YES1—tendon—systemic lupus erythematosus	0.000201	0.00298	CbGeAlD
Vandetanib—ABL1—connective tissue—systemic lupus erythematosus	0.000199	0.00296	CbGeAlD
Vandetanib—STK10—tendon—systemic lupus erythematosus	0.000199	0.00295	CbGeAlD
Vandetanib—MKNK1—nervous system—systemic lupus erythematosus	0.000196	0.00292	CbGeAlD
Vandetanib—FYN—lung—systemic lupus erythematosus	0.000195	0.0029	CbGeAlD
Vandetanib—YES1—bone marrow—systemic lupus erythematosus	0.000194	0.00289	CbGeAlD
Vandetanib—FGR—nervous system—systemic lupus erythematosus	0.000194	0.00288	CbGeAlD
Vandetanib—RET—nervous system—systemic lupus erythematosus	0.000194	0.00288	CbGeAlD
Vandetanib—ABL1—nephron tubule—systemic lupus erythematosus	0.000193	0.00287	CbGeAlD
Vandetanib—AXL—nervous system—systemic lupus erythematosus	0.000193	0.00287	CbGeAlD
Vandetanib—STK10—bone marrow—systemic lupus erythematosus	0.000193	0.00286	CbGeAlD
Vandetanib—MAP4K5—lung—systemic lupus erythematosus	0.000191	0.00283	CbGeAlD
Vandetanib—TEK—lung—systemic lupus erythematosus	0.000191	0.00283	CbGeAlD
Vandetanib—PDGFRB—kidney—systemic lupus erythematosus	0.00019	0.00283	CbGeAlD
Vandetanib—MKNK1—central nervous system—systemic lupus erythematosus	0.000189	0.00281	CbGeAlD
Vandetanib—KDR—lymphoid tissue—systemic lupus erythematosus	0.000189	0.00281	CbGeAlD
Vandetanib—FMO3—nervous system—systemic lupus erythematosus	0.000187	0.00278	CbGeAlD
Vandetanib—RET—central nervous system—systemic lupus erythematosus	0.000187	0.00277	CbGeAlD
Vandetanib—FGR—central nervous system—systemic lupus erythematosus	0.000187	0.00277	CbGeAlD
Vandetanib—AXL—central nervous system—systemic lupus erythematosus	0.000186	0.00276	CbGeAlD
Vandetanib—PDGFRB—cortex of kidney—systemic lupus erythematosus	0.000185	0.00275	CbGeAlD
Vandetanib—EPHB6—lung—systemic lupus erythematosus	0.000182	0.00271	CbGeAlD
Vandetanib—FYN—nervous system—systemic lupus erythematosus	0.000181	0.00268	CbGeAlD
Vandetanib—FMO3—central nervous system—systemic lupus erythematosus	0.00018	0.00268	CbGeAlD
Vandetanib—ABL1—skin of body—systemic lupus erythematosus	0.00018	0.00267	CbGeAlD
Vandetanib—MAP2K5—tendon—systemic lupus erythematosus	0.000177	0.00264	CbGeAlD
Vandetanib—KDR—tendon—systemic lupus erythematosus	0.000177	0.00264	CbGeAlD
Vandetanib—MAP4K5—nervous system—systemic lupus erythematosus	0.000176	0.00262	CbGeAlD
Vandetanib—TEK—nervous system—systemic lupus erythematosus	0.000176	0.00262	CbGeAlD
Vandetanib—YES1—lung—systemic lupus erythematosus	0.000176	0.00262	CbGeAlD
Vandetanib—STK10—lung—systemic lupus erythematosus	0.000174	0.00259	CbGeAlD
Vandetanib—FYN—central nervous system—systemic lupus erythematosus	0.000174	0.00258	CbGeAlD
Vandetanib—KDR—bone marrow—systemic lupus erythematosus	0.000172	0.00256	CbGeAlD
Vandetanib—MAP4K5—central nervous system—systemic lupus erythematosus	0.00017	0.00253	CbGeAlD
Vandetanib—TEK—central nervous system—systemic lupus erythematosus	0.00017	0.00253	CbGeAlD
Vandetanib—ABL1—kidney—systemic lupus erythematosus	0.00017	0.00252	CbGeAlD
Vandetanib—SRC—lung—systemic lupus erythematosus	0.000169	0.00252	CbGeAlD
Vandetanib—EPHB6—nervous system—systemic lupus erythematosus	0.000169	0.00251	CbGeAlD
Vandetanib—ABL1—cortex of kidney—systemic lupus erythematosus	0.000165	0.00246	CbGeAlD
Vandetanib—CYP3A4—blood plasma—systemic lupus erythematosus	0.000164	0.00244	CbGeAlD
Vandetanib—PDGFRB—lymphoid tissue—systemic lupus erythematosus	0.000163	0.00243	CbGeAlD
Vandetanib—YES1—nervous system—systemic lupus erythematosus	0.000163	0.00242	CbGeAlD
Vandetanib—EPHB6—central nervous system—systemic lupus erythematosus	0.000162	0.00241	CbGeAlD
Vandetanib—STK10—nervous system—systemic lupus erythematosus	0.000162	0.0024	CbGeAlD
Vandetanib—YES1—central nervous system—systemic lupus erythematosus	0.000157	0.00233	CbGeAlD
Vandetanib—SRC—nervous system—systemic lupus erythematosus	0.000157	0.00233	CbGeAlD
Vandetanib—KDR—lung—systemic lupus erythematosus	0.000156	0.00232	CbGeAlD
Vandetanib—MAP2K5—lung—systemic lupus erythematosus	0.000156	0.00232	CbGeAlD
Vandetanib—STK10—central nervous system—systemic lupus erythematosus	0.000156	0.00231	CbGeAlD
Vandetanib—PDGFRB—tendon—systemic lupus erythematosus	0.000154	0.00228	CbGeAlD
Vandetanib—SRC—central nervous system—systemic lupus erythematosus	0.000151	0.00224	CbGeAlD
Vandetanib—PDGFRB—bone marrow—systemic lupus erythematosus	0.000149	0.00221	CbGeAlD
Vandetanib—ABL1—lymphoid tissue—systemic lupus erythematosus	0.000146	0.00217	CbGeAlD
Vandetanib—KDR—nervous system—systemic lupus erythematosus	0.000144	0.00214	CbGeAlD
Vandetanib—MAP2K5—nervous system—systemic lupus erythematosus	0.000144	0.00214	CbGeAlD
Vandetanib—ORM1—bone marrow—systemic lupus erythematosus	0.00014	0.00207	CbGeAlD
Vandetanib—MAP2K5—central nervous system—systemic lupus erythematosus	0.000139	0.00206	CbGeAlD
Vandetanib—KDR—central nervous system—systemic lupus erythematosus	0.000139	0.00206	CbGeAlD
Vandetanib—ABL1—tendon—systemic lupus erythematosus	0.000137	0.00204	CbGeAlD
Vandetanib—PDGFRB—lung—systemic lupus erythematosus	0.000135	0.002	CbGeAlD
Vandetanib—ABL1—bone marrow—systemic lupus erythematosus	0.000133	0.00197	CbGeAlD
Vandetanib—ORM1—lung—systemic lupus erythematosus	0.000126	0.00188	CbGeAlD
Vandetanib—ABCC1—cortex of kidney—systemic lupus erythematosus	0.000126	0.00187	CbGeAlD
Vandetanib—PDGFRB—nervous system—systemic lupus erythematosus	0.000125	0.00186	CbGeAlD
Vandetanib—ABCG2—nephron tubule—systemic lupus erythematosus	0.000122	0.00181	CbGeAlD
Vandetanib—PDGFRB—central nervous system—systemic lupus erythematosus	0.00012	0.00179	CbGeAlD
Vandetanib—ABL1—lung—systemic lupus erythematosus	0.00012	0.00179	CbGeAlD
Vandetanib—ORM1—nervous system—systemic lupus erythematosus	0.000117	0.00174	CbGeAlD
Vandetanib—ORM1—central nervous system—systemic lupus erythematosus	0.000113	0.00168	CbGeAlD
Vandetanib—ABL1—nervous system—systemic lupus erythematosus	0.000111	0.00165	CbGeAlD
Vandetanib—VEGFA—Dexamethasone—Hydrocortisone—systemic lupus erythematosus	0.000111	0.0912	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Hydrocortisone—systemic lupus erythematosus	0.000111	0.0912	CbGdCrCtD
Vandetanib—ABL1—central nervous system—systemic lupus erythematosus	0.000107	0.00159	CbGeAlD
Vandetanib—VEGFA—Betamethasone—Methylprednisolone—systemic lupus erythematosus	0.000105	0.0861	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Methylprednisolone—systemic lupus erythematosus	0.000105	0.0861	CbGdCrCtD
Vandetanib—ABCC1—tendon—systemic lupus erythematosus	0.000104	0.00155	CbGeAlD
Vandetanib—VEGFA—Betamethasone—Dexamethasone—systemic lupus erythematosus	0.000103	0.0847	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Betamethasone—systemic lupus erythematosus	0.000103	0.0847	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Triamcinolone—systemic lupus erythematosus	0.000101	0.0828	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Triamcinolone—systemic lupus erythematosus	0.000101	0.0828	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Prednisone—systemic lupus erythematosus	9.54e-05	0.0786	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Prednisone—systemic lupus erythematosus	9.54e-05	0.0786	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Prednisolone—systemic lupus erythematosus	9.31e-05	0.0767	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Prednisolone—systemic lupus erythematosus	9.31e-05	0.0767	CbGdCrCtD
Vandetanib—Erlotinib—ALB—systemic lupus erythematosus	9.19e-05	0.0226	CrCbGaD
Vandetanib—ABCC1—lung—systemic lupus erythematosus	9.15e-05	0.00136	CbGeAlD
Vandetanib—ABCG2—bone marrow—systemic lupus erythematosus	8.36e-05	0.00124	CbGeAlD
Vandetanib—ABCG2—lung—systemic lupus erythematosus	7.58e-05	0.00113	CbGeAlD
Vandetanib—CYP3A4—kidney—systemic lupus erythematosus	7.45e-05	0.00111	CbGeAlD
Vandetanib—Gefitinib—ALB—systemic lupus erythematosus	5.75e-05	0.0141	CrCbGaD
Vandetanib—Skin disorder—Hydrocortisone—systemic lupus erythematosus	5.16e-05	0.000595	CcSEcCtD
Vandetanib—Fatigue—Cyclosporine—systemic lupus erythematosus	5.16e-05	0.000594	CcSEcCtD
Vandetanib—Headache—Azathioprine—systemic lupus erythematosus	5.14e-05	0.000592	CcSEcCtD
Vandetanib—Stevens-Johnson syndrome—Methotrexate—systemic lupus erythematosus	5.14e-05	0.000592	CcSEcCtD
Vandetanib—Dyspepsia—Mycophenolate mofetil—systemic lupus erythematosus	5.14e-05	0.000592	CcSEcCtD
Vandetanib—Dizziness—Leflunomide—systemic lupus erythematosus	5.12e-05	0.000591	CcSEcCtD
Vandetanib—Pain—Cyclosporine—systemic lupus erythematosus	5.11e-05	0.000589	CcSEcCtD
Vandetanib—Constipation—Cyclosporine—systemic lupus erythematosus	5.11e-05	0.000589	CcSEcCtD
Vandetanib—Dry mouth—Triamcinolone—systemic lupus erythematosus	5.11e-05	0.000588	CcSEcCtD
Vandetanib—Renal failure—Methotrexate—systemic lupus erythematosus	5.09e-05	0.000587	CcSEcCtD
Vandetanib—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	5.07e-05	0.000585	CcSEcCtD
Vandetanib—Stomatitis—Methotrexate—systemic lupus erythematosus	5.05e-05	0.000582	CcSEcCtD
Vandetanib—Angiopathy—Prednisone—systemic lupus erythematosus	5.05e-05	0.000582	CcSEcCtD
Vandetanib—Conjunctivitis—Methotrexate—systemic lupus erythematosus	5.04e-05	0.000581	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	5.04e-05	0.000581	CcSEcCtD
Vandetanib—Oedema—Triamcinolone—systemic lupus erythematosus	5.01e-05	0.000577	CcSEcCtD
Vandetanib—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	4.99e-05	0.000575	CcSEcCtD
Vandetanib—Pain—Mycophenolate mofetil—systemic lupus erythematosus	4.99e-05	0.000575	CcSEcCtD
Vandetanib—Arrhythmia—Prednisone—systemic lupus erythematosus	4.97e-05	0.000573	CcSEcCtD
Vandetanib—Infection—Triamcinolone—systemic lupus erythematosus	4.97e-05	0.000573	CcSEcCtD
Vandetanib—Infection—Methylprednisolone—systemic lupus erythematosus	4.96e-05	0.000572	CcSEcCtD
Vandetanib—Haematuria—Methotrexate—systemic lupus erythematosus	4.94e-05	0.000569	CcSEcCtD
Vandetanib—Vomiting—Leflunomide—systemic lupus erythematosus	4.93e-05	0.000568	CcSEcCtD
Vandetanib—Insomnia—Prednisolone—systemic lupus erythematosus	4.92e-05	0.000567	CcSEcCtD
Vandetanib—Alopecia—Prednisone—systemic lupus erythematosus	4.92e-05	0.000567	CcSEcCtD
Vandetanib—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	4.9e-05	0.000565	CcSEcCtD
Vandetanib—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	4.9e-05	0.000564	CcSEcCtD
Vandetanib—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	4.89e-05	0.000564	CcSEcCtD
Vandetanib—Loss of consciousness—Betamethasone—systemic lupus erythematosus	4.89e-05	0.000564	CcSEcCtD
Vandetanib—Loss of consciousness—Dexamethasone—systemic lupus erythematosus	4.89e-05	0.000564	CcSEcCtD
Vandetanib—Epistaxis—Methotrexate—systemic lupus erythematosus	4.89e-05	0.000563	CcSEcCtD
Vandetanib—CYP3A4—nervous system—systemic lupus erythematosus	4.89e-05	0.000727	CbGeAlD
Vandetanib—Paraesthesia—Prednisolone—systemic lupus erythematosus	4.89e-05	0.000563	CcSEcCtD
Vandetanib—Rash—Leflunomide—systemic lupus erythematosus	4.89e-05	0.000563	CcSEcCtD
Vandetanib—Dermatitis—Leflunomide—systemic lupus erythematosus	4.88e-05	0.000563	CcSEcCtD
Vandetanib—Mental disorder—Prednisone—systemic lupus erythematosus	4.88e-05	0.000562	CcSEcCtD
Vandetanib—Nausea—Azathioprine—systemic lupus erythematosus	4.87e-05	0.000562	CcSEcCtD
Vandetanib—Headache—Leflunomide—systemic lupus erythematosus	4.85e-05	0.00056	CcSEcCtD
Vandetanib—Skin disorder—Methylprednisolone—systemic lupus erythematosus	4.85e-05	0.000559	CcSEcCtD
Vandetanib—Malnutrition—Prednisone—systemic lupus erythematosus	4.85e-05	0.000558	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	4.84e-05	0.000558	CcSEcCtD
Vandetanib—Convulsion—Dexamethasone—systemic lupus erythematosus	4.82e-05	0.000556	CcSEcCtD
Vandetanib—Convulsion—Betamethasone—systemic lupus erythematosus	4.82e-05	0.000556	CcSEcCtD
Vandetanib—Insomnia—Hydrocortisone—systemic lupus erythematosus	4.81e-05	0.000554	CcSEcCtD
Vandetanib—Hypertension—Betamethasone—systemic lupus erythematosus	4.8e-05	0.000554	CcSEcCtD
Vandetanib—Hypertension—Dexamethasone—systemic lupus erythematosus	4.8e-05	0.000554	CcSEcCtD
Vandetanib—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	4.77e-05	0.00055	CcSEcCtD
Vandetanib—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	4.77e-05	0.00055	CcSEcCtD
Vandetanib—Body temperature increased—Cyclosporine—systemic lupus erythematosus	4.73e-05	0.000545	CcSEcCtD
Vandetanib—Abdominal pain—Cyclosporine—systemic lupus erythematosus	4.73e-05	0.000545	CcSEcCtD
Vandetanib—Anxiety—Dexamethasone—systemic lupus erythematosus	4.72e-05	0.000544	CcSEcCtD
Vandetanib—Anxiety—Betamethasone—systemic lupus erythematosus	4.72e-05	0.000544	CcSEcCtD
Vandetanib—CYP3A4—central nervous system—systemic lupus erythematosus	4.71e-05	0.0007	CbGeAlD
Vandetanib—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	4.68e-05	0.000539	CcSEcCtD
Vandetanib—Haemoglobin—Methotrexate—systemic lupus erythematosus	4.68e-05	0.000539	CcSEcCtD
Vandetanib—Pain—Prednisolone—systemic lupus erythematosus	4.65e-05	0.000536	CcSEcCtD
Vandetanib—Haemorrhage—Methotrexate—systemic lupus erythematosus	4.65e-05	0.000536	CcSEcCtD
Vandetanib—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	4.62e-05	0.000533	CcSEcCtD
Vandetanib—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	4.61e-05	0.000532	CcSEcCtD
Vandetanib—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	4.61e-05	0.000532	CcSEcCtD
Vandetanib—Nausea—Leflunomide—systemic lupus erythematosus	4.6e-05	0.000531	CcSEcCtD
Vandetanib—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	4.59e-05	0.000529	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	4.59e-05	0.000529	CcSEcCtD
Vandetanib—Fatigue—Hydrocortisone—systemic lupus erythematosus	4.58e-05	0.000528	CcSEcCtD
Vandetanib—Vision blurred—Prednisone—systemic lupus erythematosus	4.57e-05	0.000526	CcSEcCtD
Vandetanib—Urethral disorder—Methotrexate—systemic lupus erythematosus	4.56e-05	0.000526	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	4.56e-05	0.000526	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	4.55e-05	0.000524	CcSEcCtD
Vandetanib—Pain—Hydrocortisone—systemic lupus erythematosus	4.55e-05	0.000524	CcSEcCtD
Vandetanib—Oedema—Dexamethasone—systemic lupus erythematosus	4.54e-05	0.000523	CcSEcCtD
Vandetanib—Oedema—Betamethasone—systemic lupus erythematosus	4.54e-05	0.000523	CcSEcCtD
Vandetanib—Insomnia—Triamcinolone—systemic lupus erythematosus	4.53e-05	0.000522	CcSEcCtD
Vandetanib—Insomnia—Methylprednisolone—systemic lupus erythematosus	4.52e-05	0.000521	CcSEcCtD
Vandetanib—Infection—Dexamethasone—systemic lupus erythematosus	4.51e-05	0.00052	CcSEcCtD
Vandetanib—Infection—Betamethasone—systemic lupus erythematosus	4.51e-05	0.00052	CcSEcCtD
Vandetanib—Paraesthesia—Triamcinolone—systemic lupus erythematosus	4.49e-05	0.000518	CcSEcCtD
Vandetanib—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	4.48e-05	0.000517	CcSEcCtD
Vandetanib—Visual impairment—Methotrexate—systemic lupus erythematosus	4.48e-05	0.000517	CcSEcCtD
Vandetanib—Dyspnoea—Triamcinolone—systemic lupus erythematosus	4.46e-05	0.000514	CcSEcCtD
Vandetanib—Nervous system disorder—Betamethasone—systemic lupus erythematosus	4.45e-05	0.000513	CcSEcCtD
Vandetanib—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	4.45e-05	0.000513	CcSEcCtD
Vandetanib—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	4.45e-05	0.000512	CcSEcCtD
Vandetanib—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	4.45e-05	0.000512	CcSEcCtD
Vandetanib—Dyspepsia—Triamcinolone—systemic lupus erythematosus	4.41e-05	0.000508	CcSEcCtD
Vandetanib—Erythema multiforme—Methotrexate—systemic lupus erythematosus	4.4e-05	0.000507	CcSEcCtD
Vandetanib—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	4.4e-05	0.000507	CcSEcCtD
Vandetanib—Eye disorder—Methotrexate—systemic lupus erythematosus	4.35e-05	0.000501	CcSEcCtD
Vandetanib—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	4.35e-05	0.000501	CcSEcCtD
Vandetanib—Cardiac disorder—Methotrexate—systemic lupus erythematosus	4.32e-05	0.000498	CcSEcCtD
Vandetanib—Fatigue—Triamcinolone—systemic lupus erythematosus	4.32e-05	0.000497	CcSEcCtD
Vandetanib—Fatigue—Methylprednisolone—systemic lupus erythematosus	4.31e-05	0.000496	CcSEcCtD
Vandetanib—Asthenia—Cyclosporine—systemic lupus erythematosus	4.29e-05	0.000495	CcSEcCtD
Vandetanib—Pain—Triamcinolone—systemic lupus erythematosus	4.28e-05	0.000493	CcSEcCtD
Vandetanib—Loss of consciousness—Prednisone—systemic lupus erythematosus	4.26e-05	0.000491	CcSEcCtD
Vandetanib—Pruritus—Cyclosporine—systemic lupus erythematosus	4.23e-05	0.000488	CcSEcCtD
Vandetanib—Angiopathy—Methotrexate—systemic lupus erythematosus	4.22e-05	0.000486	CcSEcCtD
Vandetanib—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	4.2e-05	0.000484	CcSEcCtD
Vandetanib—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	4.2e-05	0.000484	CcSEcCtD
Vandetanib—Convulsion—Prednisone—systemic lupus erythematosus	4.2e-05	0.000484	CcSEcCtD
Vandetanib—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	4.19e-05	0.000483	CcSEcCtD
Vandetanib—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	4.19e-05	0.000482	CcSEcCtD
Vandetanib—Hypertension—Prednisone—systemic lupus erythematosus	4.18e-05	0.000482	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	4.14e-05	0.000477	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	4.14e-05	0.000477	CcSEcCtD
Vandetanib—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	4.13e-05	0.000476	CcSEcCtD
Vandetanib—Arthralgia—Prednisone—systemic lupus erythematosus	4.13e-05	0.000475	CcSEcCtD
Vandetanib—Anxiety—Prednisone—systemic lupus erythematosus	4.11e-05	0.000474	CcSEcCtD
Vandetanib—Alopecia—Methotrexate—systemic lupus erythematosus	4.11e-05	0.000474	CcSEcCtD
Vandetanib—Insomnia—Dexamethasone—systemic lupus erythematosus	4.11e-05	0.000473	CcSEcCtD
Vandetanib—Insomnia—Betamethasone—systemic lupus erythematosus	4.11e-05	0.000473	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	4.1e-05	0.000472	CcSEcCtD
Vandetanib—Diarrhoea—Cyclosporine—systemic lupus erythematosus	4.09e-05	0.000472	CcSEcCtD
Vandetanib—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	4.08e-05	0.000471	CcSEcCtD
Vandetanib—Paraesthesia—Betamethasone—systemic lupus erythematosus	4.08e-05	0.00047	CcSEcCtD
Vandetanib—Paraesthesia—Dexamethasone—systemic lupus erythematosus	4.08e-05	0.00047	CcSEcCtD
Vandetanib—Mental disorder—Methotrexate—systemic lupus erythematosus	4.08e-05	0.00047	CcSEcCtD
Vandetanib—Malnutrition—Methotrexate—systemic lupus erythematosus	4.05e-05	0.000467	CcSEcCtD
Vandetanib—Dyspepsia—Dexamethasone—systemic lupus erythematosus	4e-05	0.000461	CcSEcCtD
Vandetanib—Dyspepsia—Betamethasone—systemic lupus erythematosus	4e-05	0.000461	CcSEcCtD
Vandetanib—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	3.99e-05	0.00046	CcSEcCtD
Vandetanib—Dysgeusia—Methotrexate—systemic lupus erythematosus	3.97e-05	0.000457	CcSEcCtD
Vandetanib—Body temperature increased—Triamcinolone—systemic lupus erythematosus	3.96e-05	0.000456	CcSEcCtD
Vandetanib—Dizziness—Cyclosporine—systemic lupus erythematosus	3.96e-05	0.000456	CcSEcCtD
Vandetanib—Oedema—Prednisone—systemic lupus erythematosus	3.95e-05	0.000456	CcSEcCtD
Vandetanib—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	3.95e-05	0.000455	CcSEcCtD
Vandetanib—Decreased appetite—Betamethasone—systemic lupus erythematosus	3.95e-05	0.000455	CcSEcCtD
Vandetanib—Decreased appetite—Dexamethasone—systemic lupus erythematosus	3.95e-05	0.000455	CcSEcCtD
Vandetanib—Infection—Prednisone—systemic lupus erythematosus	3.93e-05	0.000453	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	3.92e-05	0.000452	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	3.92e-05	0.000452	CcSEcCtD
Vandetanib—Fatigue—Dexamethasone—systemic lupus erythematosus	3.92e-05	0.000451	CcSEcCtD
Vandetanib—Fatigue—Betamethasone—systemic lupus erythematosus	3.92e-05	0.000451	CcSEcCtD
Vandetanib—Pain—Betamethasone—systemic lupus erythematosus	3.88e-05	0.000448	CcSEcCtD
Vandetanib—Pain—Dexamethasone—systemic lupus erythematosus	3.88e-05	0.000448	CcSEcCtD
Vandetanib—Nervous system disorder—Prednisone—systemic lupus erythematosus	3.88e-05	0.000447	CcSEcCtD
Vandetanib—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	3.86e-05	0.000445	CcSEcCtD
Vandetanib—Skin disorder—Prednisone—systemic lupus erythematosus	3.84e-05	0.000443	CcSEcCtD
Vandetanib—Vision blurred—Methotrexate—systemic lupus erythematosus	3.82e-05	0.00044	CcSEcCtD
Vandetanib—Asthenia—Hydrocortisone—systemic lupus erythematosus	3.81e-05	0.00044	CcSEcCtD
Vandetanib—Vomiting—Cyclosporine—systemic lupus erythematosus	3.8e-05	0.000438	CcSEcCtD
Vandetanib—Rash—Cyclosporine—systemic lupus erythematosus	3.77e-05	0.000435	CcSEcCtD
Vandetanib—Dermatitis—Cyclosporine—systemic lupus erythematosus	3.77e-05	0.000434	CcSEcCtD
Vandetanib—Pruritus—Hydrocortisone—systemic lupus erythematosus	3.76e-05	0.000433	CcSEcCtD
Vandetanib—Headache—Cyclosporine—systemic lupus erythematosus	3.75e-05	0.000432	CcSEcCtD
Vandetanib—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	3.71e-05	0.000428	CcSEcCtD
Vandetanib—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	3.71e-05	0.000428	CcSEcCtD
Vandetanib—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	3.71e-05	0.000428	CcSEcCtD
Vandetanib—Rash—Mycophenolate mofetil—systemic lupus erythematosus	3.68e-05	0.000424	CcSEcCtD
Vandetanib—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	3.68e-05	0.000424	CcSEcCtD
Vandetanib—Headache—Mycophenolate mofetil—systemic lupus erythematosus	3.66e-05	0.000421	CcSEcCtD
Vandetanib—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	3.64e-05	0.000419	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	3.6e-05	0.000415	CcSEcCtD
Vandetanib—Dizziness—Prednisolone—systemic lupus erythematosus	3.6e-05	0.000415	CcSEcCtD
Vandetanib—Asthenia—Triamcinolone—systemic lupus erythematosus	3.59e-05	0.000414	CcSEcCtD
Vandetanib—Abdominal pain—Betamethasone—systemic lupus erythematosus	3.59e-05	0.000414	CcSEcCtD
Vandetanib—Abdominal pain—Dexamethasone—systemic lupus erythematosus	3.59e-05	0.000414	CcSEcCtD
Vandetanib—Body temperature increased—Dexamethasone—systemic lupus erythematosus	3.59e-05	0.000414	CcSEcCtD
Vandetanib—Body temperature increased—Betamethasone—systemic lupus erythematosus	3.59e-05	0.000414	CcSEcCtD
Vandetanib—Asthenia—Methylprednisolone—systemic lupus erythematosus	3.58e-05	0.000413	CcSEcCtD
Vandetanib—Insomnia—Prednisone—systemic lupus erythematosus	3.58e-05	0.000412	CcSEcCtD
Vandetanib—Nausea—Cyclosporine—systemic lupus erythematosus	3.55e-05	0.000409	CcSEcCtD
Vandetanib—Paraesthesia—Prednisone—systemic lupus erythematosus	3.55e-05	0.000409	CcSEcCtD
Vandetanib—Pruritus—Triamcinolone—systemic lupus erythematosus	3.54e-05	0.000408	CcSEcCtD
Vandetanib—Cough—Methotrexate—systemic lupus erythematosus	3.53e-05	0.000407	CcSEcCtD
Vandetanib—Pruritus—Methylprednisolone—systemic lupus erythematosus	3.53e-05	0.000407	CcSEcCtD
Vandetanib—Dizziness—Hydrocortisone—systemic lupus erythematosus	3.52e-05	0.000405	CcSEcCtD
Vandetanib—Convulsion—Methotrexate—systemic lupus erythematosus	3.51e-05	0.000404	CcSEcCtD
Vandetanib—Dyspepsia—Prednisone—systemic lupus erythematosus	3.48e-05	0.000401	CcSEcCtD
Vandetanib—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	3.47e-05	0.000399	CcSEcCtD
Vandetanib—Arthralgia—Methotrexate—systemic lupus erythematosus	3.45e-05	0.000397	CcSEcCtD
Vandetanib—Chest pain—Methotrexate—systemic lupus erythematosus	3.45e-05	0.000397	CcSEcCtD
Vandetanib—Decreased appetite—Prednisone—systemic lupus erythematosus	3.44e-05	0.000396	CcSEcCtD
Vandetanib—Rash—Prednisolone—systemic lupus erythematosus	3.43e-05	0.000395	CcSEcCtD
Vandetanib—Dermatitis—Prednisolone—systemic lupus erythematosus	3.43e-05	0.000395	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	3.42e-05	0.000395	CcSEcCtD
Vandetanib—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	3.42e-05	0.000394	CcSEcCtD
Vandetanib—Fatigue—Prednisone—systemic lupus erythematosus	3.41e-05	0.000393	CcSEcCtD
Vandetanib—Headache—Prednisolone—systemic lupus erythematosus	3.41e-05	0.000393	CcSEcCtD
Vandetanib—Constipation—Prednisone—systemic lupus erythematosus	3.38e-05	0.00039	CcSEcCtD
Vandetanib—Vomiting—Hydrocortisone—systemic lupus erythematosus	3.38e-05	0.000389	CcSEcCtD
Vandetanib—Rash—Hydrocortisone—systemic lupus erythematosus	3.35e-05	0.000386	CcSEcCtD
Vandetanib—Dermatitis—Hydrocortisone—systemic lupus erythematosus	3.35e-05	0.000386	CcSEcCtD
Vandetanib—Headache—Hydrocortisone—systemic lupus erythematosus	3.33e-05	0.000384	CcSEcCtD
Vandetanib—Dizziness—Triamcinolone—systemic lupus erythematosus	3.31e-05	0.000381	CcSEcCtD
Vandetanib—Dizziness—Methylprednisolone—systemic lupus erythematosus	3.3e-05	0.000381	CcSEcCtD
Vandetanib—Infection—Methotrexate—systemic lupus erythematosus	3.28e-05	0.000378	CcSEcCtD
Vandetanib—Asthenia—Dexamethasone—systemic lupus erythematosus	3.26e-05	0.000376	CcSEcCtD
Vandetanib—Asthenia—Betamethasone—systemic lupus erythematosus	3.26e-05	0.000376	CcSEcCtD
Vandetanib—Nervous system disorder—Methotrexate—systemic lupus erythematosus	3.24e-05	0.000374	CcSEcCtD
Vandetanib—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	3.24e-05	0.000373	CcSEcCtD
Vandetanib—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	3.23e-05	0.000373	CcSEcCtD
Vandetanib—Nausea—Prednisolone—systemic lupus erythematosus	3.23e-05	0.000373	CcSEcCtD
Vandetanib—Pruritus—Dexamethasone—systemic lupus erythematosus	3.21e-05	0.00037	CcSEcCtD
Vandetanib—Pruritus—Betamethasone—systemic lupus erythematosus	3.21e-05	0.00037	CcSEcCtD
Vandetanib—Skin disorder—Methotrexate—systemic lupus erythematosus	3.21e-05	0.00037	CcSEcCtD
Vandetanib—Vomiting—Triamcinolone—systemic lupus erythematosus	3.18e-05	0.000367	CcSEcCtD
Vandetanib—Vomiting—Methylprednisolone—systemic lupus erythematosus	3.18e-05	0.000366	CcSEcCtD
Vandetanib—Nausea—Hydrocortisone—systemic lupus erythematosus	3.16e-05	0.000364	CcSEcCtD
Vandetanib—Rash—Triamcinolone—systemic lupus erythematosus	3.16e-05	0.000364	CcSEcCtD
Vandetanib—Dermatitis—Triamcinolone—systemic lupus erythematosus	3.15e-05	0.000363	CcSEcCtD
Vandetanib—Rash—Methylprednisolone—systemic lupus erythematosus	3.15e-05	0.000363	CcSEcCtD
Vandetanib—Dermatitis—Methylprednisolone—systemic lupus erythematosus	3.15e-05	0.000363	CcSEcCtD
Vandetanib—Headache—Triamcinolone—systemic lupus erythematosus	3.14e-05	0.000361	CcSEcCtD
Vandetanib—Headache—Methylprednisolone—systemic lupus erythematosus	3.13e-05	0.000361	CcSEcCtD
Vandetanib—Abdominal pain—Prednisone—systemic lupus erythematosus	3.13e-05	0.00036	CcSEcCtD
Vandetanib—Body temperature increased—Prednisone—systemic lupus erythematosus	3.13e-05	0.00036	CcSEcCtD
Vandetanib—Diarrhoea—Dexamethasone—systemic lupus erythematosus	3.11e-05	0.000358	CcSEcCtD
Vandetanib—Diarrhoea—Betamethasone—systemic lupus erythematosus	3.11e-05	0.000358	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	3.01e-05	0.000347	CcSEcCtD
Vandetanib—Dizziness—Dexamethasone—systemic lupus erythematosus	3e-05	0.000346	CcSEcCtD
Vandetanib—Dizziness—Betamethasone—systemic lupus erythematosus	3e-05	0.000346	CcSEcCtD
Vandetanib—Insomnia—Methotrexate—systemic lupus erythematosus	2.99e-05	0.000345	CcSEcCtD
Vandetanib—Nausea—Triamcinolone—systemic lupus erythematosus	2.97e-05	0.000343	CcSEcCtD
Vandetanib—Paraesthesia—Methotrexate—systemic lupus erythematosus	2.97e-05	0.000342	CcSEcCtD
Vandetanib—Nausea—Methylprednisolone—systemic lupus erythematosus	2.97e-05	0.000342	CcSEcCtD
Vandetanib—Dyspnoea—Methotrexate—systemic lupus erythematosus	2.95e-05	0.00034	CcSEcCtD
Vandetanib—Dyspepsia—Methotrexate—systemic lupus erythematosus	2.91e-05	0.000335	CcSEcCtD
Vandetanib—Vomiting—Dexamethasone—systemic lupus erythematosus	2.89e-05	0.000333	CcSEcCtD
Vandetanib—Vomiting—Betamethasone—systemic lupus erythematosus	2.89e-05	0.000333	CcSEcCtD
Vandetanib—Decreased appetite—Methotrexate—systemic lupus erythematosus	2.87e-05	0.000331	CcSEcCtD
Vandetanib—Rash—Betamethasone—systemic lupus erythematosus	2.86e-05	0.00033	CcSEcCtD
Vandetanib—Rash—Dexamethasone—systemic lupus erythematosus	2.86e-05	0.00033	CcSEcCtD
Vandetanib—Dermatitis—Dexamethasone—systemic lupus erythematosus	2.86e-05	0.00033	CcSEcCtD
Vandetanib—Dermatitis—Betamethasone—systemic lupus erythematosus	2.86e-05	0.00033	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	2.85e-05	0.000329	CcSEcCtD
Vandetanib—Fatigue—Methotrexate—systemic lupus erythematosus	2.85e-05	0.000328	CcSEcCtD
Vandetanib—Headache—Dexamethasone—systemic lupus erythematosus	2.85e-05	0.000328	CcSEcCtD
Vandetanib—Headache—Betamethasone—systemic lupus erythematosus	2.85e-05	0.000328	CcSEcCtD
Vandetanib—Asthenia—Prednisone—systemic lupus erythematosus	2.84e-05	0.000327	CcSEcCtD
Vandetanib—Pain—Methotrexate—systemic lupus erythematosus	2.83e-05	0.000326	CcSEcCtD
Vandetanib—Pruritus—Prednisone—systemic lupus erythematosus	2.8e-05	0.000322	CcSEcCtD
Vandetanib—Diarrhoea—Prednisone—systemic lupus erythematosus	2.71e-05	0.000312	CcSEcCtD
Vandetanib—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	2.7e-05	0.000311	CcSEcCtD
Vandetanib—Nausea—Betamethasone—systemic lupus erythematosus	2.7e-05	0.000311	CcSEcCtD
Vandetanib—Nausea—Dexamethasone—systemic lupus erythematosus	2.7e-05	0.000311	CcSEcCtD
Vandetanib—Dizziness—Prednisone—systemic lupus erythematosus	2.62e-05	0.000301	CcSEcCtD
Vandetanib—Body temperature increased—Methotrexate—systemic lupus erythematosus	2.61e-05	0.000301	CcSEcCtD
Vandetanib—Abdominal pain—Methotrexate—systemic lupus erythematosus	2.61e-05	0.000301	CcSEcCtD
Vandetanib—Vomiting—Prednisone—systemic lupus erythematosus	2.51e-05	0.00029	CcSEcCtD
Vandetanib—Rash—Prednisone—systemic lupus erythematosus	2.49e-05	0.000287	CcSEcCtD
Vandetanib—Dermatitis—Prednisone—systemic lupus erythematosus	2.49e-05	0.000287	CcSEcCtD
Vandetanib—Headache—Prednisone—systemic lupus erythematosus	2.48e-05	0.000286	CcSEcCtD
Vandetanib—Asthenia—Methotrexate—systemic lupus erythematosus	2.37e-05	0.000273	CcSEcCtD
Vandetanib—Nausea—Prednisone—systemic lupus erythematosus	2.35e-05	0.000271	CcSEcCtD
Vandetanib—Pruritus—Methotrexate—systemic lupus erythematosus	2.34e-05	0.000269	CcSEcCtD
Vandetanib—Diarrhoea—Methotrexate—systemic lupus erythematosus	2.26e-05	0.000261	CcSEcCtD
Vandetanib—Dizziness—Methotrexate—systemic lupus erythematosus	2.19e-05	0.000252	CcSEcCtD
Vandetanib—Vomiting—Methotrexate—systemic lupus erythematosus	2.1e-05	0.000242	CcSEcCtD
Vandetanib—Rash—Methotrexate—systemic lupus erythematosus	2.08e-05	0.00024	CcSEcCtD
Vandetanib—Dermatitis—Methotrexate—systemic lupus erythematosus	2.08e-05	0.00024	CcSEcCtD
Vandetanib—Headache—Methotrexate—systemic lupus erythematosus	2.07e-05	0.000239	CcSEcCtD
Vandetanib—Nausea—Methotrexate—systemic lupus erythematosus	1.96e-05	0.000226	CcSEcCtD
Vandetanib—ERBB3—Signaling Pathways—IL2—systemic lupus erythematosus	1.47e-06	1.26e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—TYK2—systemic lupus erythematosus	1.46e-06	1.25e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—IL2—systemic lupus erythematosus	1.46e-06	1.25e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—NOS3—systemic lupus erythematosus	1.46e-06	1.25e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—PTGS2—systemic lupus erythematosus	1.46e-06	1.25e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—F2—systemic lupus erythematosus	1.46e-06	1.25e-05	CbGpPWpGaD
Vandetanib—BLK—Immune System—IL6—systemic lupus erythematosus	1.45e-06	1.25e-05	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—IL6—systemic lupus erythematosus	1.45e-06	1.25e-05	CbGpPWpGaD
Vandetanib—FGR—Immune System—IL6—systemic lupus erythematosus	1.45e-06	1.24e-05	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—IL6—systemic lupus erythematosus	1.44e-06	1.24e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—MMP9—systemic lupus erythematosus	1.44e-06	1.23e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—JAK1—systemic lupus erythematosus	1.44e-06	1.23e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.43e-06	1.23e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—CDKN1B—systemic lupus erythematosus	1.43e-06	1.23e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—CDKN1A—systemic lupus erythematosus	1.43e-06	1.22e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—F2—systemic lupus erythematosus	1.43e-06	1.22e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IFNG—systemic lupus erythematosus	1.42e-06	1.22e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—PPARG—systemic lupus erythematosus	1.42e-06	1.22e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—CD80—systemic lupus erythematosus	1.42e-06	1.21e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.41e-06	1.21e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CCR5—systemic lupus erythematosus	1.41e-06	1.21e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—MMP9—systemic lupus erythematosus	1.4e-06	1.2e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—F2—systemic lupus erythematosus	1.4e-06	1.2e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—TYK2—systemic lupus erythematosus	1.4e-06	1.2e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—CDKN1A—systemic lupus erythematosus	1.4e-06	1.2e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.4e-06	1.2e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CD80—systemic lupus erythematosus	1.4e-06	1.2e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—CDKN1A—systemic lupus erythematosus	1.39e-06	1.19e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.39e-06	1.19e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—MMP9—systemic lupus erythematosus	1.39e-06	1.19e-05	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—IL2—systemic lupus erythematosus	1.39e-06	1.19e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.38e-06	1.18e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—IL2—systemic lupus erythematosus	1.38e-06	1.18e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—C3—systemic lupus erythematosus	1.38e-06	1.18e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—CDKN1B—systemic lupus erythematosus	1.38e-06	1.18e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—CDKN1A—systemic lupus erythematosus	1.38e-06	1.18e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—NOS3—systemic lupus erythematosus	1.38e-06	1.18e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CD4—systemic lupus erythematosus	1.37e-06	1.18e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IFNG—systemic lupus erythematosus	1.37e-06	1.17e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CD80—systemic lupus erythematosus	1.37e-06	1.17e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—EP300—systemic lupus erythematosus	1.36e-06	1.17e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.36e-06	1.17e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.36e-06	1.17e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CCR5—systemic lupus erythematosus	1.36e-06	1.17e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—EP300—systemic lupus erythematosus	1.36e-06	1.17e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—TYK2—systemic lupus erythematosus	1.35e-06	1.16e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CD80—systemic lupus erythematosus	1.35e-06	1.15e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—CD4—systemic lupus erythematosus	1.34e-06	1.15e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.34e-06	1.15e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—PTGS2—systemic lupus erythematosus	1.33e-06	1.14e-05	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—IL6—systemic lupus erythematosus	1.33e-06	1.14e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—IL2—systemic lupus erythematosus	1.33e-06	1.14e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—EP300—systemic lupus erythematosus	1.33e-06	1.14e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—C3—systemic lupus erythematosus	1.33e-06	1.14e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—EP300—systemic lupus erythematosus	1.33e-06	1.14e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—EP300—systemic lupus erythematosus	1.33e-06	1.14e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—NOS3—systemic lupus erythematosus	1.33e-06	1.13e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—CD4—systemic lupus erythematosus	1.32e-06	1.13e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—CDKN1A—systemic lupus erythematosus	1.32e-06	1.13e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—EP300—systemic lupus erythematosus	1.32e-06	1.13e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.32e-06	1.13e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—EP300—systemic lupus erythematosus	1.31e-06	1.12e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CCL2—systemic lupus erythematosus	1.3e-06	1.11e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.3e-06	1.11e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—TYK2—systemic lupus erythematosus	1.29e-06	1.11e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.29e-06	1.11e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CDKN1B—systemic lupus erythematosus	1.29e-06	1.1e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—IL2—systemic lupus erythematosus	1.29e-06	1.1e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—ALB—systemic lupus erythematosus	1.28e-06	1.09e-05	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—IL6—systemic lupus erythematosus	1.27e-06	1.09e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—CDKN1A—systemic lupus erythematosus	1.27e-06	1.09e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—JAK1—systemic lupus erythematosus	1.27e-06	1.09e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CCL2—systemic lupus erythematosus	1.27e-06	1.09e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—CD4—systemic lupus erythematosus	1.27e-06	1.08e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—CDKN1B—systemic lupus erythematosus	1.26e-06	1.08e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL2—systemic lupus erythematosus	1.26e-06	1.08e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—MMP9—systemic lupus erythematosus	1.26e-06	1.08e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.26e-06	1.08e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—PTGS2—systemic lupus erythematosus	1.26e-06	1.08e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.26e-06	1.08e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—EP300—systemic lupus erythematosus	1.26e-06	1.08e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CCL2—systemic lupus erythematosus	1.25e-06	1.07e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—PPARG—systemic lupus erythematosus	1.25e-06	1.07e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.25e-06	1.07e-05	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—EP300—systemic lupus erythematosus	1.24e-06	1.07e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—CDKN1B—systemic lupus erythematosus	1.24e-06	1.06e-05	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—IL6—systemic lupus erythematosus	1.23e-06	1.05e-05	CbGpPWpGaD
Vandetanib—ERBB3—Disease—IL6—systemic lupus erythematosus	1.23e-06	1.05e-05	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—IL6—systemic lupus erythematosus	1.23e-06	1.05e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—NOS3—systemic lupus erythematosus	1.22e-06	1.05e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—RXRA—systemic lupus erythematosus	1.22e-06	1.05e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—CD4—systemic lupus erythematosus	1.22e-06	1.05e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.22e-06	1.04e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL2—systemic lupus erythematosus	1.22e-06	1.04e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.21e-06	1.04e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—IFNG—systemic lupus erythematosus	1.21e-06	1.04e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—F2—systemic lupus erythematosus	1.21e-06	1.04e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—PTGS2—systemic lupus erythematosus	1.21e-06	1.04e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—EP300—systemic lupus erythematosus	1.21e-06	1.04e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CCR5—systemic lupus erythematosus	1.21e-06	1.03e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—EP300—systemic lupus erythematosus	1.2e-06	1.02e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—TYK2—systemic lupus erythematosus	1.2e-06	1.02e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—CDKN1B—systemic lupus erythematosus	1.19e-06	1.02e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CDKN1A—systemic lupus erythematosus	1.19e-06	1.02e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.19e-06	1.02e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.19e-06	1.02e-05	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—VEGFA—systemic lupus erythematosus	1.18e-06	1.01e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—TYK2—systemic lupus erythematosus	1.18e-06	1.01e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—C3—systemic lupus erythematosus	1.18e-06	1.01e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	1.18e-06	1.01e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—NOS3—systemic lupus erythematosus	1.17e-06	1e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD4—systemic lupus erythematosus	1.17e-06	1e-05	CbGpPWpGaD
Vandetanib—YES1—Immune System—IL6—systemic lupus erythematosus	1.17e-06	1e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—F2—systemic lupus erythematosus	1.17e-06	1e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—CDKN1A—systemic lupus erythematosus	1.17e-06	9.99e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CD80—systemic lupus erythematosus	1.16e-06	9.95e-06	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.16e-06	9.9e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—NOS3—systemic lupus erythematosus	1.16e-06	9.9e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—EP300—systemic lupus erythematosus	1.15e-06	9.89e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TYK2—systemic lupus erythematosus	1.15e-06	9.88e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—CDKN1B—systemic lupus erythematosus	1.15e-06	9.83e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—CDKN1A—systemic lupus erythematosus	1.15e-06	9.83e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.14e-06	9.79e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TYK2—systemic lupus erythematosus	1.14e-06	9.72e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.13e-06	9.7e-06	CbGpPWpGaD
Vandetanib—EGFR—Immune System—EP300—systemic lupus erythematosus	1.13e-06	9.7e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—NOS3—systemic lupus erythematosus	1.13e-06	9.7e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—ALB—systemic lupus erythematosus	1.12e-06	9.63e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CD80—systemic lupus erythematosus	1.12e-06	9.59e-06	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—PTGS2—systemic lupus erythematosus	1.12e-06	9.57e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—NOS3—systemic lupus erythematosus	1.11e-06	9.55e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—EP300—systemic lupus erythematosus	1.11e-06	9.5e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—CDKN1B—systemic lupus erythematosus	1.1e-06	9.43e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—CDKN1A—systemic lupus erythematosus	1.1e-06	9.41e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.09e-06	9.37e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—TGFB1—systemic lupus erythematosus	1.09e-06	9.35e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—EP300—systemic lupus erythematosus	1.09e-06	9.35e-06	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—IL6—systemic lupus erythematosus	1.09e-06	9.31e-06	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—TGFB1—systemic lupus erythematosus	1.08e-06	9.27e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—CD4—systemic lupus erythematosus	1.08e-06	9.26e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CCL2—systemic lupus erythematosus	1.08e-06	9.25e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL2—systemic lupus erythematosus	1.08e-06	9.22e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—NOS3—systemic lupus erythematosus	1.08e-06	9.21e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—PTGS2—systemic lupus erythematosus	1.07e-06	9.19e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—CDKN1A—systemic lupus erythematosus	1.06e-06	9.07e-06	CbGpPWpGaD
Vandetanib—FYN—Disease—TGFB1—systemic lupus erythematosus	1.05e-06	9.01e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—EP300—systemic lupus erythematosus	1.05e-06	8.96e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CCL2—systemic lupus erythematosus	1.04e-06	8.92e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.04e-06	8.9e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—F2—systemic lupus erythematosus	1.03e-06	8.86e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—CDKN1B—systemic lupus erythematosus	1.02e-06	8.7e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—CDKN1A—systemic lupus erythematosus	1.02e-06	8.7e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—EP300—systemic lupus erythematosus	1.01e-06	8.63e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—TGFB1—systemic lupus erythematosus	1e-06	8.6e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1e-06	8.58e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CD80—systemic lupus erythematosus	9.91e-07	8.49e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—PTGS2—systemic lupus erythematosus	9.83e-07	8.42e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TYK2—systemic lupus erythematosus	9.81e-07	8.4e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CDKN1B—systemic lupus erythematosus	9.81e-07	8.4e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—IL2—systemic lupus erythematosus	9.8e-07	8.39e-06	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—IL6—systemic lupus erythematosus	9.78e-07	8.37e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—EP300—systemic lupus erythematosus	9.66e-07	8.28e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CDKN1B—systemic lupus erythematosus	9.65e-07	8.27e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—TGFB1—systemic lupus erythematosus	9.65e-07	8.26e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—NOS3—systemic lupus erythematosus	9.63e-07	8.25e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—IL2—systemic lupus erythematosus	9.6e-07	8.22e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TYK2—systemic lupus erythematosus	9.45e-07	8.1e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—IL2—systemic lupus erythematosus	9.45e-07	8.09e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—CDKN1A—systemic lupus erythematosus	9.38e-07	8.03e-06	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—EP300—systemic lupus erythematosus	9.29e-07	7.96e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—NOS3—systemic lupus erythematosus	9.28e-07	7.95e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—MMP9—systemic lupus erythematosus	9.28e-07	7.95e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CDKN1A—systemic lupus erythematosus	9.24e-07	7.92e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CCL2—systemic lupus erythematosus	9.22e-07	7.89e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—TGFB1—systemic lupus erythematosus	9.09e-07	7.79e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—MMP9—systemic lupus erythematosus	9.08e-07	7.78e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CDKN1A—systemic lupus erythematosus	9.05e-07	7.75e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—MMP9—systemic lupus erythematosus	8.94e-07	7.66e-06	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—IL6—systemic lupus erythematosus	8.94e-07	7.66e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—EP300—systemic lupus erythematosus	8.92e-07	7.64e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IL6—systemic lupus erythematosus	8.91e-07	7.63e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CDKN1A—systemic lupus erythematosus	8.91e-07	7.63e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—EP300—systemic lupus erythematosus	8.8e-07	7.53e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—TGFB1—systemic lupus erythematosus	8.76e-07	7.5e-06	CbGpPWpGaD
Vandetanib—LYN—Immune System—IL6—systemic lupus erythematosus	8.72e-07	7.47e-06	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—IL6—systemic lupus erythematosus	8.71e-07	7.46e-06	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IL6—systemic lupus erythematosus	8.68e-07	7.44e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—IL6—systemic lupus erythematosus	8.62e-07	7.38e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—EP300—systemic lupus erythematosus	8.61e-07	7.38e-06	CbGpPWpGaD
Vandetanib—FYN—Immune System—IL6—systemic lupus erythematosus	8.59e-07	7.36e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—EP300—systemic lupus erythematosus	8.48e-07	7.26e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TYK2—systemic lupus erythematosus	8.37e-07	7.17e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CDKN1B—systemic lupus erythematosus	8.34e-07	7.14e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.33e-07	7.13e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—IL6—systemic lupus erythematosus	8.23e-07	7.05e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—NOS3—systemic lupus erythematosus	8.21e-07	7.04e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—EP300—systemic lupus erythematosus	8.18e-07	7e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL2—systemic lupus erythematosus	8.16e-07	6.99e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.16e-07	6.99e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—IL6—systemic lupus erythematosus	8.12e-07	6.96e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CDKN1B—systemic lupus erythematosus	8.04e-07	6.88e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.03e-07	6.88e-06	CbGpPWpGaD
Vandetanib—FYN—Disease—IL6—systemic lupus erythematosus	7.93e-07	6.79e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL2—systemic lupus erythematosus	7.87e-07	6.74e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—IL6—systemic lupus erythematosus	7.83e-07	6.71e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—TGFB1—systemic lupus erythematosus	7.76e-07	6.64e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—MMP9—systemic lupus erythematosus	7.73e-07	6.62e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PPARG—systemic lupus erythematosus	7.71e-07	6.61e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CDKN1A—systemic lupus erythematosus	7.7e-07	6.59e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.65e-07	6.55e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—IL6—systemic lupus erythematosus	7.56e-07	6.48e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.49e-07	6.41e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—MMP9—systemic lupus erythematosus	7.44e-07	6.38e-06	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL6—systemic lupus erythematosus	7.42e-07	6.36e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CDKN1A—systemic lupus erythematosus	7.42e-07	6.35e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.37e-07	6.31e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—EP300—systemic lupus erythematosus	7.32e-07	6.27e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—IL6—systemic lupus erythematosus	7.27e-07	6.23e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL6—systemic lupus erythematosus	7.15e-07	6.12e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CDKN1B—systemic lupus erythematosus	7.12e-07	6.09e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—EP300—systemic lupus erythematosus	7.06e-07	6.05e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL2—systemic lupus erythematosus	6.96e-07	5.96e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—VEGFA—systemic lupus erythematosus	6.94e-07	5.94e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—IL6—systemic lupus erythematosus	6.85e-07	5.87e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—VEGFA—systemic lupus erythematosus	6.69e-07	5.73e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—NOS3—systemic lupus erythematosus	6.63e-07	5.68e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—IL6—systemic lupus erythematosus	6.6e-07	5.65e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	6.59e-07	5.65e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MMP9—systemic lupus erythematosus	6.59e-07	5.64e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.57e-07	5.62e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TGFB1—systemic lupus erythematosus	6.37e-07	5.45e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL6—systemic lupus erythematosus	6.33e-07	5.42e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—EP300—systemic lupus erythematosus	6.25e-07	5.35e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TGFB1—systemic lupus erythematosus	6.14e-07	5.25e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PTGS2—systemic lupus erythematosus	6.07e-07	5.2e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.92e-07	5.07e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—IL6—systemic lupus erythematosus	5.85e-07	5.01e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—IL6—systemic lupus erythematosus	5.76e-07	4.93e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—IL6—systemic lupus erythematosus	5.64e-07	4.83e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—IL6—systemic lupus erythematosus	5.55e-07	4.76e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.43e-07	4.65e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—EP300—systemic lupus erythematosus	5.05e-07	4.32e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL6—systemic lupus erythematosus	4.8e-07	4.11e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL6—systemic lupus erythematosus	4.62e-07	3.96e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	4.16e-07	3.57e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL6—systemic lupus erythematosus	4.09e-07	3.51e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	3.74e-07	3.21e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	3.58e-07	3.07e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	3.28e-07	2.81e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	2.72e-07	2.33e-06	CbGpPWpGaD
